SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-4.76%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$1.85B
AUM Growth
+$1.85B
(-1.1%)
Cap. Flow
+$57.9M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
47.07%
Holding
109
New
9
Increased
31
Reduced
10
Closed
22
Top Buys
| 1 |
Microsoft
MSFT
|
$68.9M |
| 2 |
Chipotle Mexican Grill
CMG
|
$37.4M |
| 3 |
Amazon
AMZN
|
$37.1M |
| 4 |
Advanced Micro Devices
AMD
|
$33.5M |
| 5 |
Royalty Pharma
RPRX
|
$28.5M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$67.2M |
| 2 |
Spyre Therapeutics
SYRE
|
$47.7M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$28.8M |
| 4 |
TSMC
TSM
|
$23.9M |
| 5 |
Accenture
ACN
|
$21.6M |
Sector Composition
| 1 | Healthcare | 62.92% |
| 2 | Consumer Discretionary | 12.25% |
| 3 | Technology | 11.13% |
| 4 | Communication Services | 4.55% |
| 5 | Industrials | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$15.6B
| $111M | 6.01% | 4,095,745 +1,048,696 | +34% | +$28.5M |
|
2
Biohaven
BHVN
$1.63B
| $104M | 5.63% | 4,005,600 +138,042 | +4% | +$3.59M |
|
3
Arcellx
ACLX
$3.85B
| $103M | 5.56% | 2,869,967 +21,800 | +0.8% | +$782K |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $91M | 4.92% | 786,313 -7,042 | -0.9% | -$815K |
|
5
Insmed
INSM
$28.8B
| $87M | 4.7% | 3,446,334 +337,000 | +11% | +$8.51M |
|
6
Meta Platforms (Facebook)
META
$1.86T
| $84.3M | 4.55% | 280,645 +29,415 | +12% | +$8.83M |
|
|
7
Amazon
AMZN
$2.44T
| $78.7M | 4.26% | 619,469 +291,556 | +89% | +$37.1M |
|
|
8
Advanced Micro Devices
AMD
$264B
| $71.6M | 3.87% | 696,510 +325,903 | +88% | +$33.5M |
|
|
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $71.4M | 3.86% | 1,369,849 +170,878 | +14% | +$8.9M |
|
|
10
Microsoft
MSFT
$3.77T
| $68.9M | 3.72% | +218,170 | New | +$68.9M |
|
11
Kura Oncology
KURA
$686M
| $66.9M | 3.62% | 7,335,845 +307,403 | +4% | +$2.8M |
|
12
Wynn Resorts
WYNN
$13.2B
| $42.5M | 2.3% | 460,048 +161,390 | +54% | +$14.9M |
|
|
MRNS
13
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $41.9M | 2.26% | 5,204,942 +1,147,331 | +28% | +$9.24M |
|
14
89bio
ETNB
$1.34B
| $41.6M | 2.25% | 2,694,404 +301,168 | +13% | +$4.65M |
|
15
GE Aerospace
GE
$292B
| $38.8M | 2.1% | 350,969 +158,235 | +82% | +$17.5M |
|
16
NVIDIA
NVDA
$4.24T
| $38.5M | 2.08% | 88,548 +11,056 | +14% | +$4.81M |
|
|
17
Chipotle Mexican Grill
CMG
$56.5B
| $37.4M | 2.02% | +20,400 | New | +$37.4M |
|
18
Global Payments
GPN
$21.5B
| $32.8M | 1.77% | 284,488 +3,300 | +1% | +$381K |
|
19
Terns Pharmaceuticals
TERN
$609M
| $30.4M | 1.64% | 6,041,910 +480,075 | +9% | +$2.41M |
|
20
Cogent Biosciences
COGT
$1.69B
| $29.8M | 1.61% | 3,053,300 +833,607 | +38% | +$8.13M |
|
21
Las Vegas Sands
LVS
$39.6B
| $29.5M | 1.59% | 642,833 -42,400 | -6% | -$1.94M |
|
22
EyePoint Pharmaceuticals
EYPT
$797M
| $27.9M | 1.51% | 3,492,147 +68,250 | +2% | +$545K |
|
23
Oracle
ORCL
$635B
| $27M | 1.46% | 255,311 -63,114 | -20% | -$6.69M |
|
24
Fulcrum Therapeutics
FULC
$351M
| $25.4M | 1.37% | 5,718,881 | – | – |
|
25
Ultragenyx Pharmaceutical
RARE
$2.89B
| $24.2M | 1.31% | 679,459 +137,979 | +25% | +$4.92M |
|